Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...
The global lateral flow assay (LFA) market is projected to grow from USD 10.01 billion in 2024 to USD 15.42 billion by 2030, driven by increasing demand for point-of-care testing and the rising ...
NEW YORK, NY, UNITED STATES, April 27, 2026 /EINPresswire.com/ -- With years of experience in the pharmaceutical and ...
Lateral flow assay applications have become increasingly diverse in a post-pandemic world, and the areas of infectious disease and oncology continue to be at the forefront. In both areas, the use of ...
CHICAGO, Feb. 26, 2024 /PRNewswire/ -- Lateral Flow Assays Market in terms of revenue was estimated to be worth $10.8 billion in 2023 and is poised to reach $16.8 billion by 2029, growing at a CAGR of ...
In this interview, News-Medical talks to Hasret Altan-Martin from Sartorius about the ongoing emergence of lateral flow assays in diagnostics. Before the COVID-19 pandemic, the pregnancy test was the ...
With the revolution of lateral flow assay use in Point-of-Care and Over-the-Counter testing resulting from Covid-19, saliva has become an attractive sample matrix. To continue to grow lateral flow ...
For many years, PCR has been the go-to method for detecting specific DNA and RNA sequences. However, its requirement for specialized thermal cyclers limits its use for rapid, on-site testing. In ...
Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.
A newly validated stall-side immunoglobulin G (IgG) lateral-flow assay for foals has shown high accuracy and repeatability compared to gold-standard laboratory methods. The portable test enables ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results